We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-5.21%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$6.31B
AUM Growth
-$1.31B
Cap. Flow
-$452M
Cap. Flow %
-7.17%
Top 10 Hldgs %
37.6%
Holding
304
New
27
Increased
63
Reduced
157
Closed
47

Top Buys

Rank Stock Value
1
TWOU
2U Inc
TWOU
+$75.8M
2
ADPT
Adeptus Health Inc
ADPT
+$73.7M
3
SHAK icon
Shake Shack
SHAK
+$53.8M
4
ULTA icon
Ulta Beauty
ULTA
+$45.2M
5
BWLD
Buffalo Wild Wings, Inc.
BWLD
+$43.1M

Top Sells

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$61.2M
2
TWTR
Twitter, Inc.
TWTR
+$55.8M
3
ESPR
Esperion Therapeutics
ESPR
+$51.1M
4
JD icon
JD.com
JD
+$50.8M
5
ZG icon
Zillow
ZG
+$45.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.45%
2 Healthcare 20.34%
3 Communication Services 17.82%
4 Technology 17.65%
5 Miscellaneous 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALGN icon
201
Align Technology
ALGN
$10.6B
$503K 0.01%
8,859
-29
-0.3% -$1.73K
LXFT
202
DELISTED
Luxoft Holding, Inc.
LXFT
$502K 0.01%
7,924
-32,555
-80% -$2.03M
ONCE
203
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$492K 0.01%
11,802
-180,414
-94% -$9.42M
RPD icon
204
Rapid7
RPD
$846M
$459K 0.01%
+20,187
New +$449K
HAIN icon
205
Hain Celestial
HAIN
$53.3M
$455K 0.01%
8,823
-148
-2% -$9.37K
CHTR icon
206
Charter Communications
CHTR
$16.8B
$450K 0.01%
2,557
+666
+35% +$122K
RGNX icon
207
Regenxbio
RGNX
$522M
$440K 0.01%
+19,995
New +$510K
GFN
208
DELISTED
General Finance Corporation
GFN
$439K 0.01%
118,609
-20,152
-15% -$85.9K
NWHM
209
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$436K 0.01%
33,662
-652
-2% -$9.96K
LLY icon
210
Eli Lilly
LLY
$1.02T
$434K 0.01%
+5,184
New +$438K
GILD icon
211
Gilead Sciences
GILD
$180B
$423K 0.01%
4,307
+1,548
+56% +$172K
ATHN
212
DELISTED
Athenahealth, Inc.
ATHN
$414K 0.01%
3,101
-3
-0.1% -$391
TVRD
213
Tvardi Therapeutics
TVRD
$24.1M
$399K 0.01%
+776
New +$519K
QUNR
214
DELISTED
Qunar Cayman Islands Limited
QUNR
$359K 0.01%
11,932
-8,425
-41% -$308K
TRVN
215
DELISTED
Trevena, Inc.
TRVN
$340K 0.01%
+53
New +$262K
PODD icon
216
Insulet
PODD
$9.64B
$336K 0.01%
12,980
-56
-0.4% -$1.7K
EBAY icon
217
eBay
EBAY
$48.1B
$327K 0.01%
13,378
-48,861
-79% -$1.31M
AKBA icon
218
Akebia Therapeutics
AKBA
$258M
$326K 0.01%
+33,733
New +$310K
SRPT icon
219
Sarepta Therapeutics
SRPT
$2.2B
$267K ﹤0.01%
8,327
-12
-0.1% -$407
ZTS icon
220
Zoetis
ZTS
$30.4B
$263K ﹤0.01%
6,379
+1,474
+30% +$68.4K
HAPN
221
Happen Inc
HAPN
$1.89B
$252K ﹤0.01%
3,814
-185,321
-98% -$12.6M
ETSY icon
222
Etsy
ETSY
$6.85B
$228K ﹤0.01%
16,666
+12,434
+294% +$195K
CSII
223
DELISTED
Cardiovascular Systems, Inc.
CSII
$191K ﹤0.01%
12,084
-6,856
-36% -$173K
YELP icon
224
Yelp
YELP
$1.15B
$176K ﹤0.01%
8,114
-274,717
-97% -$7.62M
RNG icon
225
RingCentral
RNG
$6.06B
$173K ﹤0.01%
9,507
+8,217
+637% +$150K
7 8
9
10 11

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Gilder Gagnon Howe & Co held 304 positions worth $6.31B, down 17% from $7.61B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $452M in Q3 2015, closing 47 positions and reducing 157 holdings. Its most notable exit was Silicon Laboratories, an estimated $28.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Adeptus Health Inc worth $57.7M.

  • Gilder Gagnon Howe & Co's largest Q3 2015 buy was Adeptus Health Inc: 714,509 shares worth $57.7M.
  • Gilder Gagnon Howe & Co added most to 2U Inc in Q3 2015, an estimated $75.8M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2015 reduction was Akamai, cutting an estimated $61.2M.
  • Gilder Gagnon Howe & Co fully exited Silicon Laboratories in Q3 2015, selling an estimated $28.1M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 38% of its $6.31B portfolio in Q3 2015.
  • Gilder Gagnon Howe & Co opened 27 new positions and closed 47 in Q3 2015.
  • Gilder Gagnon Howe & Co's portfolio value fell 17% quarter-over-quarter to $6.31B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2015, filed 9 Nov 2015.